Direkt zum Inhalt
Merck
  • Attenuation of erythrocytic acetyl cholinesterase by paracetamol and chloroquine: evidence in an in vitro study.

Attenuation of erythrocytic acetyl cholinesterase by paracetamol and chloroquine: evidence in an in vitro study.

Pakistan journal of pharmaceutical sciences (2014-03-01)
Shafiq Ahmad Tariq, Haroon Khan, Abdul Jalil Popalzai, Iftikhar-ud-Din Niazi, Safiullah
ZUSAMMENFASSUNG

The present study deals with the erythrocytic acetylcholinesterase inhibitory activity of paracetamol and chloroquine in an in vitro protocol using Michaelis Menten parameters (Apparent Michaelis Constant (aKm) and Apparent Maximum Velocity (aVm). Paracetamol showed marked inhibition of the erythrocytic acetylcholinesterase. The inhibitory values for aKm and aVm were 65.6% 51.36% respectively, which reduced with respect to control and therefore, proposed an un-competitive type of antagonism. When chloroquine was tested, it showed 45.14% inhibition for aKm which increased while 69.21% for aVm decreased with respect to control; proposed a mixed type of antagonism. In conclusion, the cholinergic intervention by paracetamol in this study suggested a new mechanism for its analgesic activity as acetylcholinesterase inhibitors have already shown both peripheral and central analgesic activity, while the cholinergic activation by chloroquine provided explanation for some of its side effects.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Acetylcholinesterase aus Electrophorus electricus (electric eel), Type VI-S, lyophilized powder, 200-1,000 units/mg protein
Sigma-Aldrich
Acetylcholinesterase aus Electrophorus electricus (electric eel), Type V-S, lyophilized powder, ≥1,000 units/mg protein
Sigma-Aldrich
Acetylcholinesterase human, recombinant, expressed in HEK 293 cells, lyophilized powder, ≥1,000 units/mg protein (Lowry)
Sigma-Aldrich
Acetylcholinesterase aus Humanerythrocyten, buffered aqueous solution, ≥500 units/mg protein (BCA)